首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use.
【24h】

Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use.

机译:与隧道式袖套式血液透析导管相比,临时的非隧道式导管在使用2周内已经带来更多并发症。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Comparison of outcome of untunnelled catheters (UCs) and tunnelled cuffed catheters (TCCs) is difficult because they are usually used for different patients and conditions. The aim of the present study is to compare the outcome of TCCs with UCs limiting as much as possible the influence of confounding factors. The second purpose was to see whether our results support the time recommendations for maximum use of UCs outlined in the NKF-DOQI guidelines. METHODS: Catheter and patient characteristics, catheter-related complications and all cultures taken from haemodialysis catheters inserted during a 3 year period were collected. RESULTS: We analysed the outcome of 272 catheters (149 patients, 11 612 catheter-days, 37 TCC and 235 UC). Patients with an UC suffered more often from acute renal failure (40 vs 8% for TCCs, P<0.001), their hospitalization rates were higher (54 vs 14%, P<0.001) and coumarins were used less (11 vs 27%, P<0.01). Rates of preliminary removal were 1.8 per 1000 catheter-days for TCCs, 35.3 for untunnelled femoral catheters (UFCs) and 17.1 for untunnelled jugular catheters (UJCs). Infection rates were 2.9 per 1000 catheter-days for TCCs, 15.6 for UJCs and 20.2 for UFCs. Hospitalization was an independent risk factor for an adverse outcome and more apparent in patients with an UC. After correction for patient differences, the strongest risk factor for preliminary removal (RR 9.69, P<0.001) and infection (RR 3.76, P<0.001) was having an UC inserted. Already, within 2 weeks actuarial and infection-free survival were better for TCCs (P<0.05 vs all separate groups). CONCLUSIONS: According to our results, a TCC should be used whenever it can be foreseen that a haemodialysis catheter is needed for more than 14 days.
机译:背景:比较非隧道式导管(UCs)和隧道式袖套导管(TCCs)的结果是困难的,因为它们通常用于不同的患者和病情。本研究的目的是比较TCCs与UCs的结果,以尽可能地限制混杂因素的影响。第二个目的是查看我们的结果是否支持NKF-DOQI指南中概述的最大程度使用UC的时间建议。方法:收集导管和患者的特征,与导管相关的并发症以及在3年内从血液透析导管中取出的所有培养物。结果:我们分析了272根导管的结果(149例患者,11 612导管日,37例TCC和235 UC)。患有UC的患者更容易遭受急性肾衰竭(TCCs为40 vs 8%,P <0.001),其住院率更高(54 vs 14%,P <0.001),而香豆素的使用较少(11 vs 27%, P <0.01)。对于TCC,初步清除率为每1000个导管日1.8个,对于非隧道式股动脉导管(UFC)为35.3,对于非隧道式颈静脉导管(UJC)为17.1。 TCC的感染率为每1000个导管日2.9,UJC的感染率为15.6,UFC的感染率为20.2。住院是不良后果的独立危险因素,在UC患者中更为明显。校正患者差异后,初步移除(RR 9.69,P <0.001)和感染(RR 3.76,P <0.001)的最强危险因素是插入了UC。在2周内,TCC的精算和无感染生存期更好(与所有单独组相比,P <0.05)。结论:根据我们的结果,只要可以预见需要血液透析导管超过14天,就应使用TCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号